1840 related articles for article (PubMed ID: 33743843)
21. Alternative Dose Allocation Strategies to Increase Benefits From Constrained COVID-19 Vaccine Supply.
Tuite AR; Zhu L; Fisman DN; Salomon JA
Ann Intern Med; 2021 Apr; 174(4):570-572. PubMed ID: 33395334
[No Abstract] [Full Text] [Related]
22. Evaluating SARS-CoV-2 Vaccines After Emergency Use Authorization or Licensing of Initial Candidate Vaccines.
Joffe S
JAMA; 2021 Jan; 325(3):221-222. PubMed ID: 33315069
[No Abstract] [Full Text] [Related]
23. Vaccines for COVID-19: Where do we stand in 2021?
Sharma K; Koirala A; Nicolopoulos K; Chiu C; Wood N; Britton PN
Paediatr Respir Rev; 2021 Sep; 39():22-31. PubMed ID: 34362666
[TBL] [Abstract][Full Text] [Related]
24. Venezuela is collapsing without COVID-19 vaccines.
Loyo ESL; González MJ; Esparza J
Lancet; 2021 May; 397(10287):1806. PubMed ID: 33992140
[No Abstract] [Full Text] [Related]
25. Global COVID-19 vaccine inequity: The scope, the impact, and the challenges.
Asundi A; O'Leary C; Bhadelia N
Cell Host Microbe; 2021 Jul; 29(7):1036-1039. PubMed ID: 34265241
[TBL] [Abstract][Full Text] [Related]
26. Ethical and Scientific Considerations Regarding the Early Approval and Deployment of a COVID-19 Vaccine.
Dal-Ré R; Caplan AL; Gluud C; Porcher R
Ann Intern Med; 2021 Feb; 174(2):258-260. PubMed ID: 33216636
[TBL] [Abstract][Full Text] [Related]
27. What scientists do and don't know about the Oxford-AstraZeneca COVID vaccine.
Mallapaty S; Callaway E
Nature; 2021 Apr; 592(7852):15-17. PubMed ID: 33762708
[No Abstract] [Full Text] [Related]
28. Opting Out of Vaccines for Your Child.
Rosenthal CM; Thompson LA
JAMA Pediatr; 2020 Sep; 174(9):916. PubMed ID: 32716493
[No Abstract] [Full Text] [Related]
29. Vaccine safety - is the SARS-CoV-2 vaccine any different?
Tau N; Yahav D; Shepshelovich D
Hum Vaccin Immunother; 2021 May; 17(5):1322-1325. PubMed ID: 33270474
[TBL] [Abstract][Full Text] [Related]
30. Just allocation of COVID-19 vaccines.
Herlitz A; Lederman Z; Miller J; Fleurbaey M; Venkatapuram S; Atuire C; Eckenwiler L; Hassoun N
BMJ Glob Health; 2021 Feb; 6(2):. PubMed ID: 33589419
[No Abstract] [Full Text] [Related]
31. The long road ahead for COVID-19 vaccination in Africa.
Jerving S
Lancet; 2021 Sep; 398(10303):827-828. PubMed ID: 34481563
[No Abstract] [Full Text] [Related]
32. The UK has approved a COVID vaccine - here's what scientists now want to know.
Ledford H; Cyranoski D; Van Noorden R
Nature; 2020 Dec; 588(7837):205-206. PubMed ID: 33288887
[No Abstract] [Full Text] [Related]
33. Unfair competition under the TRIPS agreement: protection of data submitted for the registration of pharmaceuticals.
Correa CM
Chic J Int Law; 2002; 3(1):69-85. PubMed ID: 15709300
[No Abstract] [Full Text] [Related]
34. The fight to manufacture COVID vaccines in lower-income countries.
Maxmen A
Nature; 2021 Sep; 597(7877):455-457. PubMed ID: 34526695
[No Abstract] [Full Text] [Related]
35. What constitutes success in the roll-out of COVID-19 vaccines?
Smith MJ
Lancet; 2021 Jul; 398(10295):115-116. PubMed ID: 34181882
[No Abstract] [Full Text] [Related]
36. Will SARS-CoV-2 variants of concern affect the promise of vaccines?
Gupta RK
Nat Rev Immunol; 2021 Jun; 21(6):340-341. PubMed ID: 33927376
[TBL] [Abstract][Full Text] [Related]
37. Canada is no global health leader on COVID-19 vaccine equity.
Houston AR; Murthy S
Lancet; 2021 May; 397(10287):1803. PubMed ID: 33992135
[No Abstract] [Full Text] [Related]
38. COVID-19 Vaccine Distribution and Allocation: What Physicians Need to Know.
Laine C; Cotton D; Moyer DV
Ann Intern Med; 2021 Mar; 174(3):413-414. PubMed ID: 33492990
[TBL] [Abstract][Full Text] [Related]
39. Up Is Down - Pharmaceutical Industry Caution vs. Federal Acceleration of Covid-19 Vaccine Approval.
Avorn J; Kesselheim AS
N Engl J Med; 2020 Oct; 383(18):1706-1708. PubMed ID: 32931162
[No Abstract] [Full Text] [Related]
40. Africa's need for more COVID-19 clinical trials.
Makoni M
Lancet; 2021 May; 397(10289):2037. PubMed ID: 34062137
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
